Page last updated: 2024-08-16

potassium chloride and 1-(3-(5-(1,2,4-triazol-4-yl)-1h-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine

potassium chloride has been researched along with 1-(3-(5-(1,2,4-triazol-4-yl)-1h-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, RG; Longmore, J; MacLeod, A; Maguire, JJ; Schofield, WN; Street, L1

Other Studies

1 other study(ies) available for potassium chloride and 1-(3-(5-(1,2,4-triazol-4-yl)-1h-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine

ArticleYear
Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
    British journal of clinical pharmacology, 2000, Volume: 49, Issue:2

    Topics: Adult; Analysis of Variance; Coronary Vessels; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Piperazines; Potassium Chloride; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Vasoconstriction

2000